Compare AURA & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | PAYS |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 797.5M | 780.3M |
| IPO Year | 2021 | 2020 |
| Metric | AURA | PAYS |
|---|---|---|
| Price | $7.49 | $12.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $20.00 | $9.42 |
| AVG Volume (30 Days) | 807.1K | ★ 814.8K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.71 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $24,120,434.00 |
| Revenue This Year | N/A | $33.83 |
| Revenue Next Year | N/A | $14.89 |
| P/E Ratio | ★ N/A | $62.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.73 | $3.08 |
| 52 Week High | $9.54 | $14.43 |
| Indicator | AURA | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 58.76 |
| Support Level | $7.27 | $4.95 |
| Resistance Level | $7.70 | $14.43 |
| Average True Range (ATR) | 0.39 | 0.68 |
| MACD | -0.06 | -0.27 |
| Stochastic Oscillator | 38.07 | 32.13 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.